Lactobacillus rhamnosus GG Stimulates Dietary Tryptophan-Dependent Production of Barrier-Protecting Methylnicotinamide

dc.contributor.authorSuntornsaratoon P.
dc.contributor.authorAntonio J.M.
dc.contributor.authorFlores J.
dc.contributor.authorUpadhyay R.
dc.contributor.authorVeltri J.
dc.contributor.authorBandyopadhyay S.
dc.contributor.authorDadala R.
dc.contributor.authorKim M.
dc.contributor.authorLiu Y.
dc.contributor.authorBalasubramanian I.
dc.contributor.authorTurner J.R.
dc.contributor.authorSu X.
dc.contributor.authorLi W.V.
dc.contributor.authorGao N.
dc.contributor.authorFerraris R.P.
dc.contributor.correspondenceSuntornsaratoon P.
dc.contributor.otherMahidol University
dc.date.accessioned2024-06-14T18:10:13Z
dc.date.available2024-06-14T18:10:13Z
dc.date.issued2024-01-01
dc.description.abstractBackground & Aims: Lacticaseibacillus rhamnosus GG (LGG) is the world's most consumed probiotic but its mechanism of action on intestinal permeability and differentiation along with its interactions with an essential source of signaling metabolites, dietary tryptophan (trp), are unclear. Methods: Untargeted metabolomic and transcriptomic analyses were performed in LGG monocolonized germ-free mice fed trp-free or -sufficient diets. LGG-derived metabolites were profiled in vitro under anaerobic and aerobic conditions. Multiomic correlations using a newly developed algorithm discovered novel metabolites tightly linked to tight junction and cell differentiation genes whose abundances were regulated by LGG and dietary trp. Barrier-modulation by these metabolites were functionally tested in Caco2 cells, mouse enteroids, and dextran sulfate sodium experimental colitis. The contribution of these metabolites to barrier protection is delineated at specific tight junction proteins and enterocyte-promoting factors with gain and loss of function approaches. Results: LGG, strictly with dietary trp, promotes the enterocyte program and expression of tight junction genes, particularly Ocln. Functional evaluations of fecal and serum metabolites synergistically stimulated by LGG and trp revealed a novel vitamin B3 metabolism pathway, with methylnicotinamide (MNA) unexpectedly being the most robust barrier-protective metabolite in vitro and in vivo. Reduced serum MNA is significantly associated with increased disease activity in patients with inflammatory bowel disease. Exogenous MNA enhances gut barrier in homeostasis and robustly promotes colonic healing in dextran sulfate sodium colitis. MNA is sufficient to promote intestinal epithelial Ocln and RNF43, a master inhibitor of Wnt. Blocking trp or vitamin B3 absorption abolishes barrier recovery in vivo. Conclusions: Our study uncovers a novel LGG-regulated dietary trp-dependent production of MNA that protects the gut barrier against colitis.
dc.identifier.citationCellular and Molecular Gastroenterology and Hepatology Vol.18 No.2 (2024)
dc.identifier.doi10.1016/j.jcmgh.2024.04.003
dc.identifier.eissn2352345X
dc.identifier.pmid38641207
dc.identifier.scopus2-s2.0-85195415676
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/98749
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleLactobacillus rhamnosus GG Stimulates Dietary Tryptophan-Dependent Production of Barrier-Protecting Methylnicotinamide
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85195415676&origin=inward
oaire.citation.issue2
oaire.citation.titleCellular and Molecular Gastroenterology and Hepatology
oaire.citation.volume18
oairecerif.author.affiliationFederated Department of Biological Sciences
oairecerif.author.affiliationUniversity of California, Riverside
oairecerif.author.affiliationRutgers Robert Wood Johnson Medical School at New Brunswick
oairecerif.author.affiliationBrigham and Women's Hospital
oairecerif.author.affiliationMahidol University
oairecerif.author.affiliationRutgers New Jersey Medical School

Files

Collections